Literature DB >> 12427743

Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells.

Kenneth R Hallows1, Jill E McCane, Bruce E Kemp, Lee A Witters, J Kevin Foskett.   

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel activity is important for fluid and electrolyte transport in many epithelia including the lung, the site of most cystic fibrosis-associated morbidity. CFTR is unique among ion channels in requiring ATP hydrolysis for its gating, suggesting that its activity is coupled to cellular metabolic status. The metabolic sensor AMP-activated kinase (AMPK) binds to and phosphorylates CFTR, co-localizes with it in various tissues, and inhibits CFTR currents in Xenopus oocytes (Hallows, K. R., Raghuram, V., Kemp, B. E., Witters, L. A. & Foskett, J. K. (2000) J. Clin. Invest. 105, 1711-1721). Here we demonstrate that this AMPK-CFTR interaction has functional implications in human lung epithelial cells. Pharmacologic activation of AMPK inhibited forskolin-stimulated CFTR short circuit currents in polarized Calu-3 cell monolayers. In whole-cell patch clamp experiments, the activation of endogenous AMPK either pharmacologically or by the overexpression of an AMPK-activating non-catalytic subunit mutant (AMPK-gamma1-R70Q) dramatically inhibited forskolin-stimulated CFTR conductance in Calu-3 and CFTR-expressing Chinese hamster ovary cells. Plasma membrane expression of CFTR, assessed by surface biotinylation, was not affected by AMPK activation. In contrast, the single channel open probability of CFTR was strongly reduced in cell-attached patch clamp measurements of Calu-3 cells transfected with the AMPK-activating mutant, an effect due primarily to a substantial prolongation of the mean closed time of the channel. As a metabolic sensor in cells, AMPK may be important in tuning CFTR activity to cellular energy charge, thereby linking transepithelial transport and the maintenance of cellular ion gradients to cellular metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427743     DOI: 10.1074/jbc.M210621200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  AMP-activated protein kinase--development of the energy sensor concept.

Authors:  D Grahame Hardie; Simon A Hawley; John W Scott
Journal:  J Physiol       Date:  2006-04-27       Impact factor: 5.182

2.  Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells.

Authors:  Hélène Klein; Line Garneau; Nguyen Thu Ngan Trinh; Anik Privé; François Dionne; Eugénie Goupil; Dominique Thuringer; Lucie Parent; Emmanuelle Brochiero; Rémy Sauvé
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-03       Impact factor: 4.249

3.  β1Pix exchange factor stabilizes the ubiquitin ligase Nedd4-2 and plays a critical role in ENaC regulation by AMPK in kidney epithelial cells.

Authors:  Pei-Yin Ho; Hui Li; Tengis S Pavlov; Roland D Tuerk; Diego Tabares; René Brunisholz; Dietbert Neumann; Alexander Staruschenko; Kenneth R Hallows
Journal:  J Biol Chem       Date:  2018-06-01       Impact factor: 5.157

4.  AMP-activated protein kinase connects cellular energy metabolism to KATP channel function.

Authors:  Hidetada Yoshida; Li Bao; Eirini Kefaloyianni; Eylem Taskin; Uzoma Okorie; Miyoun Hong; Piyali Dhar-Chowdhury; Michiyo Kaneko; William A Coetzee
Journal:  J Mol Cell Cardiol       Date:  2011-08-24       Impact factor: 5.000

5.  Regulation of the cystic fibrosis transmembrane conductance regulator anion channel by tyrosine phosphorylation.

Authors:  Arnaud Billet; Yanlin Jia; Tim Jensen; John R Riordan; John W Hanrahan
Journal:  FASEB J       Date:  2015-06-10       Impact factor: 5.191

Review 6.  Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications.

Authors:  Michelle L McClure; Stephen Barnes; Jeffrey L Brodsky; Eric J Sorscher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

7.  Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.

Authors:  Cordula M Wolf; Michael Arad; Ferhaan Ahmad; Atsushi Sanbe; Scott A Bernstein; Okan Toka; Tetsuo Konno; Gregory Morley; Jeffrey Robbins; J G Seidman; Christine E Seidman; Charles I Berul
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

8.  AMP-activated protein kinase inhibits alkaline pH- and PKA-induced apical vacuolar H+-ATPase accumulation in epididymal clear cells.

Authors:  Kenneth R Hallows; Rodrigo Alzamora; Hui Li; Fan Gong; Christy Smolak; Dietbert Neumann; Núria M Pastor-Soler
Journal:  Am J Physiol Cell Physiol       Date:  2009-02-11       Impact factor: 4.249

9.  AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells.

Authors:  Michael M Myerburg; J Darwin King; Nicholas M Oyster; Adam C Fitch; Amy Magill; Catherine J Baty; Simon C Watkins; Jay K Kolls; Joseph M Pilewski; Kenneth R Hallows
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-17       Impact factor: 6.914

10.  Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis.

Authors:  Mario A Pagano; Giorgio Arrigoni; Oriano Marin; Stefania Sarno; Flavio Meggio; Kate J Treharne; Anil Mehta; Lorenzo A Pinna
Journal:  Biochemistry       Date:  2008-07-03       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.